Does the drug Ribavirin cure SARS?
Health Canada’s Special Access Programme (SAP) provides access to drugs that are not approved for sale in Canada for patients suffering from serious and life-threatening conditions when other marketed therapies have either failed or are unsuitable. SAP is currently providing access to intravenous and oral Ribavirin for use in SARS. These products are not approved for sale in Canada. The efficacy of Ribavirin in treating SARS is unknown, although it has been used to treat a variety of viral illnesses including Respiratory Syncytial virus, Lassa fever, and Hanta virus. SAP is working closely with health care professionals at each of the hospitals involved to gather information on the use of Ribavirin for SARS, and potential adverse effects.